Genichiro Ishii

3.4k citations
95 papers · 2.6k indexed · h-index 30
Topics
Lung Cancer Diagnosis and Treatment (35 papers)Lung Cancer Treatments and Mutations (27 papers)Cancer Cells and Metastasis (11 papers)

In The Last Decade

Genichiro Ishii

92 papers receiving 2.5k citations

Peers

Genichiro Ishii
Comparison fields: 5 of 98
  • Pulmonary and Respiratory Medicine 1.3k
  • Oncology 997
  • Molecular Biology 588
  • Cancer Research 425
  • Surgery 374
Replace Yuji Sakuma with:
Yuji Sakuma Japan
Laura Boldrini Italy
Jin-Haeng Chung South Korea
Christine Sagan France
Haruhiro Yukiue Japan
Malcolm Hayes Canada
Hideoki Yokouchi Japan
Asuka Tsuya Japan
Hirofumi Uehara Japan
Ryma Benayed United States
Genichiro Ishii relative to Yuji Sakuma Japan Yuji Sakuma's profile →
Citations per field
00.5×1.7×
Yuji Sakuma · 1×
Citations per year

Countries citing papers authored by Genichiro Ishii

Since Specialization
Citations

This map shows the geographic impact of Genichiro Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genichiro Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genichiro Ishii more than expected).

Fields of papers citing papers by Genichiro Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genichiro Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genichiro Ishii. The network helps show where Genichiro Ishii may publish in the future.

Co-authorship network of co-authors of Genichiro Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Genichiro Ishii. A scholar is included among the top collaborators of Genichiro Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genichiro Ishii. Genichiro Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 11
3 3
4 5
5 14
6 15
7 9
8 22
9 22
10 3
11 27
12 4
13 28
14 10
15 103
16 30
17 7
18 41
19 3
20 19

About Genichiro Ishii

Genichiro Ishii is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 95 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (35 papers), Lung Cancer Treatments and Mutations (27 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.3k citations), Oncology (997 citations) and Cancer Research (425 citations). Genichiro Ishii has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kanji Nagai, Atsushi Ochiai, Junji Yoshida, Mitsuyo Nishimura, Yutaka Nishiwaki, Tomoyuki Hishida, Takahiro Hasebe, Ryo Maeda, Shin’ichi Miyamoto and Tomoyuki Yokose. Their work appears in journals such as Cancer, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026